210 related articles for article (PubMed ID: 19495993)
21. Discovery of novel CK2 leads by cross-docking based virtual screening.
Sun H; Wu X; Xu X; Jiang Z; Liu Z; You Q
Med Chem; 2014; 10(6):628-39. PubMed ID: 24286395
[TBL] [Abstract][Full Text] [Related]
22. In silico fragment-based drug design with SEED.
Marchand JR; Caflisch A
Eur J Med Chem; 2018 Aug; 156():907-917. PubMed ID: 30064119
[TBL] [Abstract][Full Text] [Related]
23. Improving docking results via reranking of ensembles of ligand poses in multiple X-ray protein conformations with MM-GBSA.
Greenidge PA; Kramer C; Mozziconacci JC; Sherman W
J Chem Inf Model; 2014 Oct; 54(10):2697-717. PubMed ID: 25266271
[TBL] [Abstract][Full Text] [Related]
24. A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance.
Perola E; Walters WP; Charifson PS
Proteins; 2004 Aug; 56(2):235-49. PubMed ID: 15211508
[TBL] [Abstract][Full Text] [Related]
25. Applications of the NRGsuite and the Molecular Docking Software FlexAID in Computational Drug Discovery and Design.
Morency LP; Gaudreault F; Najmanovich R
Methods Mol Biol; 2018; 1762():367-388. PubMed ID: 29594781
[TBL] [Abstract][Full Text] [Related]
26. The discovery of quinoline-3-carboxamides as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors.
Deaton DN; Do Y; Holt J; Jeune MR; Kramer HF; Larkin AL; Orband-Miller LA; Peckham GE; Poole C; Price DJ; Schaller LT; Shen Y; Shewchuk LM; Stewart EL; Stuart JD; Thomson SA; Ward P; Wilson JW; Xu T; Guss JH; Musetti C; Rendina AR; Affleck K; Anders D; Hancock AP; Hobbs H; Hodgson ST; Hutchinson J; Leveridge MV; Nicholls H; Smith IED; Somers DO; Sneddon HF; Uddin S; Cleasby A; Mortenson PN; Richardson C; Saxty G
Bioorg Med Chem; 2019 Apr; 27(8):1456-1478. PubMed ID: 30858025
[TBL] [Abstract][Full Text] [Related]
27. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models.
Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S
J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122
[TBL] [Abstract][Full Text] [Related]
28. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments.
Sastry GM; Adzhigirey M; Day T; Annabhimoju R; Sherman W
J Comput Aided Mol Des; 2013 Mar; 27(3):221-34. PubMed ID: 23579614
[TBL] [Abstract][Full Text] [Related]
29. Ligand-biased ensemble receptor docking (LigBEnD): a hybrid ligand/receptor structure-based approach.
Lam PC; Abagyan R; Totrov M
J Comput Aided Mol Des; 2018 Jan; 32(1):187-198. PubMed ID: 28887659
[TBL] [Abstract][Full Text] [Related]
30. Improvement in the quality of hematopoietic prostaglandin D synthase crystals in a microgravity environment.
Tanaka H; Tsurumura T; Aritake K; Furubayashi N; Takahashi S; Yamanaka M; Hirota E; Sano S; Sato M; Kobayashi T; Tanaka T; Inaka K; Urade Y
J Synchrotron Radiat; 2011 Jan; 18(1):88-91. PubMed ID: 21169700
[TBL] [Abstract][Full Text] [Related]
31. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
32. Effective interaction studies for inhibition of DNA ligase protein from Staphylococcus aureus.
Vijayalakshmi P; Daisy P
J Recept Signal Transduct Res; 2015 Feb; 35(1):15-25. PubMed ID: 25055026
[TBL] [Abstract][Full Text] [Related]
33. Extensive consensus docking evaluation for ligand pose prediction and virtual screening studies.
Tuccinardi T; Poli G; Romboli V; Giordano A; Martinelli A
J Chem Inf Model; 2014 Oct; 54(10):2980-6. PubMed ID: 25211541
[TBL] [Abstract][Full Text] [Related]
34. Virtual screening of specific chemical compounds by exploring E.coli NAD+-dependent DNA ligase as a target for antibacterial drug discovery.
Akhoon BA; Gupta SK; Dhaliwal G; Srivastava M; Gupta SK
J Mol Model; 2011 Feb; 17(2):265-73. PubMed ID: 20443037
[TBL] [Abstract][Full Text] [Related]
35. Investigation of MM-PBSA rescoring of docking poses.
Thompson DC; Humblet C; Joseph-McCarthy D
J Chem Inf Model; 2008 May; 48(5):1081-91. PubMed ID: 18465849
[TBL] [Abstract][Full Text] [Related]
36. FRAGSITE: A Fragment-Based Approach for Virtual Ligand Screening.
Zhou H; Cao H; Skolnick J
J Chem Inf Model; 2021 Apr; 61(4):2074-2089. PubMed ID: 33724022
[TBL] [Abstract][Full Text] [Related]
37. Charting a Path to Success in Virtual Screening.
Forli S
Molecules; 2015 Oct; 20(10):18732-58. PubMed ID: 26501243
[TBL] [Abstract][Full Text] [Related]
38. Assessing and improving the performance of consensus docking strategies using the DockBox package.
Preto J; Gentile F
J Comput Aided Mol Des; 2019 Sep; 33(9):817-829. PubMed ID: 31578656
[TBL] [Abstract][Full Text] [Related]
39. Panel docking of small-molecule libraries - Prospects to improve efficiency of lead compound discovery.
Sarnpitak P; Mujumdar P; Taylor P; Cross M; Coster MJ; Gorse AD; Krasavin M; Hofmann A
Biotechnol Adv; 2015 Nov; 33(6 Pt 1):941-7. PubMed ID: 26025037
[TBL] [Abstract][Full Text] [Related]
40. BEAR, a novel virtual screening methodology for drug discovery.
Degliesposti G; Portioli C; Parenti MD; Rastelli G
J Biomol Screen; 2011 Jan; 16(1):129-33. PubMed ID: 21084717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
